These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21669042)

  • 1. Surface expression of HLA-G is involved in mediating immunomodulatory effects of placenta-derived multipotent cells (PDMCs) towards natural killer lymphocytes.
    Liu KJ; Wang CJ; Chang CJ; Hu HI; Hsu PJ; Wu YC; Bai CH; Sytwu HK; Yen BL
    Cell Transplant; 2011; 20(11-12):1721-30. PubMed ID: 21669042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma.
    Chang CJ; Yen ML; Chen YC; Chien CC; Huang HI; Bai CH; Yen BL
    Stem Cells; 2006 Nov; 24(11):2466-77. PubMed ID: 17071860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief report--human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes.
    Yen BL; Chang CJ; Liu KJ; Chen YC; Hu HI; Bai CH; Yen ML
    Stem Cells; 2009 Feb; 27(2):451-6. PubMed ID: 18988708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells.
    Chien CC; Yen BL; Lee FK; Lai TH; Chen YC; Chan SH; Huang HI
    Stem Cells; 2006 Jul; 24(7):1759-68. PubMed ID: 16822884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of multipotent cells from human term placenta.
    Yen BL; Huang HI; Chien CC; Jui HY; Ko BS; Yao M; Shun CT; Yen ML; Lee MC; Chen YC
    Stem Cells; 2005; 23(1):3-9. PubMed ID: 15625118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutual interaction between human multipotent adult progenitor cells and NK cells.
    Jacobs SA; Plessers J; Pinxteren J; Roobrouck VD; Verfaillie CM; Van Gool SW
    Cell Transplant; 2014; 23(9):1099-110. PubMed ID: 23562064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells.
    Banas RA; Trumpower C; Bentlejewski C; Marshall V; Sing G; Zeevi A
    Hum Immunol; 2008 Jun; 69(6):321-8. PubMed ID: 18571002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of human placenta-derived multipotent cells and in vitro differentiation into hepatocyte-like cells.
    Huang HI
    Curr Protoc Stem Cell Biol; 2007 Jun; Chapter 1():Unit 1E.1. PubMed ID: 18785166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
    Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
    Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placenta-derived multipotent cells differentiate into neuronal and glial cells in vitro.
    Yen BL; Chien CC; Chen YC; Chen JT; Huang JS; Lee FK; Huang HI
    Tissue Eng Part A; 2008 Jan; 14(1):9-17. PubMed ID: 18333820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β2-Microglobulin-free HLA-G activates natural killer cells by increasing cytotoxicity and proinflammatory cytokine production.
    Zhao L; Purandare B; Zhang J; Hantash BM
    Hum Immunol; 2013 Apr; 74(4):417-24. PubMed ID: 23228393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of RhoA kinase inhibition in human placenta-derived multipotent cells on neural phenotype and cell survival.
    Wang CH; Wu CC; Hsu SH; Liou JY; Li YW; Wu KK; Lai YK; Yen BL
    Biomaterials; 2013 Apr; 34(13):3223-30. PubMed ID: 23410680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal allograft rejection: protection of renal epithelium from natural killer cells by cytokine-induced up-regulation of class I major histocompatibility antigens.
    Lin Y; Proud G; Taylor RM; Kirby JA
    Immunology; 1993 Jun; 79(2):290-7. PubMed ID: 8344707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
    Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N
    J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
    Itoh K; Tilden AB; Balch CM
    J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.
    Le Page ME; Goodridge JP; John E; Christiansen FT; Witt CS
    J Immunol; 2014 Jan; 192(2):732-40. PubMed ID: 24337374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.